A multi-institutional, randomized, double-blinded, placebo-controlled trial of additive Duloxetine for cancerrelated neuropathic pain refractory to opioids and gabapentinoids: JORTC PAL-08 (DIRECT study)
{"title":"A multi-institutional, randomized, double-blinded, placebo-controlled trial of additive Duloxetine for cancerrelated neuropathic pain refractory to opioids and gabapentinoids: JORTC PAL-08 (DIRECT study)","authors":"pHiromichi Matsuokap","doi":"10.4172/2165-7386-C1-014","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":91127,"journal":{"name":"Journal of palliative care & medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of palliative care & medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2165-7386-C1-014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
